Dotinurad - Fuji Yakuhin/Mochida Pharmaceutical
Alternative Names: FYU-981; URECE; Urece; YurisuLatest Information Update: 14 Oct 2024
At a glance
- Originator Fuji Yakuhin
- Developer Eisai Co Ltd; Fortress Biotech; Fuji Yakuhin; Mochida Pharmaceutical; Urica Therapeutics
- Class Antigouts; Benzothiazoles; Small molecules; Uricosurics
- Mechanism of Action SLC22A12 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Gout; Hyperuricaemia